Anti-ST2 Nanoparticle Alleviates Lung Inflammation by Targeting ILC2s-CD4⁺T Response

References

• Phan HT, Vu GV, Vu GT, et al. Global mapping of research trends on interventions to improve health-related quality of life in asthma patients. Int J Environ Res Public Health. 2020;17(10):10. doi:10.3390/ijerph17103540
   Web of Science ®Google Scholar
• Gorczynski RM, Maqbool T, Hoffmann G. Mechanism(s) of prolonged attenuation of allergic responses after modulation of idiotypic regulatory network. Allergy Asthma Clin Immunol. 2019;15(1):79. doi:10.1186/s13223-019-0393-731827543
   PubMed Web of Science ®Google Scholar
• Fitzpatrick AM, Chipps BE, Holguin F, Woodruff PG. T2-”low” asthma: overview and management strategies. J Allergy Clin Immunol Pract. 2020;8(2):452–463. doi:10.1016/j.jaip.2019.11.00632037109
   PubMed Web of Science ®Google Scholar
• Peters MC, Ringel L, Dyjack N, et al. A transcriptomic method to determine airway immune dysfunction in T2-high and T2-low asthma. Am J Respir Crit Care Med. 2019;199(4):465–477. doi:10.1164/rccm.201807-1291OC30371106
   PubMed Web of Science ®Google Scholar
• Ridolo E, Pucciarini F, Nizi MC, et al. Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab. Hum Vaccin Immunother. 2020;1–8.
   PubMed Web of Science ®Google Scholar
• Nagasawa M, Heesters BA, Kradolfer CMA, et al. KLRG1 and NKp46 discriminate subpopulations of human CD117(+)CRTH2(-) ILCs biased toward ILC2 or ILC3. J Exp Med. 2019;216(8):1762–1776. doi:10.1084/jem.2019049031201208
   PubMed Web of Science ®Google Scholar
• Barlow JL, Peel S, Fox J, et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol. 2013;132(4):933–941. doi:10.1016/j.jaci.2013.05.01223810766
   PubMed Web of Science ®Google Scholar
• Frisbee AL, Saleh MM, Young MK, et al. IL-33 drives group 2 innate lymphoid cell-mediated protection during clostridium difficile infection. Nat Commun. 2019;10(1):2712. doi:10.1038/s41467-019-10733-931221971
   PubMed Web of Science ®Google Scholar
• Al Faraj A, Shaik AS, Afzal S, Al-Muhsen S, Halwani R. Specific targeting and noninvasive magnetic resonance imaging of an asthma biomarker in the lung using polyethylene glycol functionalized magnetic nanocarriers. Contrast Media Mol Imaging. 2016;11(3):172–183. doi:10.1002/cmmi.167826708935
   PubMed Web of Science ®Google Scholar
• Luo B, Zhang H, Liu X, Rao R, Wu Y, Liu W. Novel DiR and SPIO nanoparticles embedded PEG-PLGA nanobubbles as a multimodal imaging contrast agent. Biomed Mater Eng. 2015;26(Suppl 1):S911–916.26406092
   PubMedGoogle Scholar
• Song X, Gong H, Yin S, et al. Ultra-small iron oxide doped polypyrrole nanoparticles for in vivo multimodal imaging guided photothermal therapy. Adv Funct Mater. 2014;24(9):1194–1201. doi:10.1002/adfm.201302463
   Web of Science ®Google Scholar
• MacArthur Clark JA, Sun D. Guidelines for the ethical review of laboratory animal welfare People’s Republic of China national standard GB/T 35892-2018 [issued 6 February 2018 effective from 1 September 2018]. Allergy Asthma Clin Immunol. 2020;3(1):103–113. doi:10.1002/ame2.12111
   Google Scholar
• Myou S, Leff AR, Myo S, et al. Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT. J Exp Med. 2003;198(10):1573–1582. doi:10.1084/jem.2003029814623911
   PubMed Web of Science ®Google Scholar
• Verma M, Liu S, Michalec L, Sripada A, Gorska MM, Alam R. Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9(+) and IL-13(+) type 2 innate lymphoid cell subpopulations. J Allergy Clin Immunol. 2018;142(3):793–803.e798. doi:10.1016/j.jaci.2017.10.02029132961
   PubMed Web of Science ®Google Scholar
• Pasha MA, Patel G, Hopp R, Yang Q. Role of innate lymphoid cells in allergic diseases. Allergy Asthma Proc. 2019;40(3):138–145.31018888
   PubMed Web of Science ®Google Scholar
• Yu QN, Guo YB, Li X, et al. ILC2 frequency and activity are inhibited by glucocorticoid treatment via STAT pathway in patients with asthma. Allergy. 2018;73(9):1860–1870. doi:10.1111/all.1343829542140
   PubMed Web of Science ®Google Scholar
• Ying X, Su Z, Bie Q, et al. Synergistically increased ILC2 and Th9 cells in lung tissue jointly promote the pathological process of asthma in mice. Mol Med Rep. 2016;13(6):5230–5240. doi:10.3892/mmr.2016.517427109139
   PubMed Web of Science ®Google Scholar
• Komai-Koma M, Brombacher F, Pushparaj PN, et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice. Allergy. 2012;67(9):1118–1126. doi:10.1111/j.1398-9995.2012.02859.x22702477
   PubMed Web of Science ®Google Scholar
• Han X, Bai S, Cui Y, Zhu W, Zhao N, Liu B. Essential role of CD4(+) T cells for the activation of group 2 innate lymphoid cells during respiratory syncytial virus infection in mice. Immunotherapy. 2019;11(15):1303–1313. doi:10.2217/imt-2019-008431478420
   PubMed Web of Science ®Google Scholar
• McDaniel DK, Ringel-Scaia VM, Coutermarsh-Ott SL, Allen IC. Utilizing the lung as a model to study nanoparticle-based drug delivery systems. Methods Mol Biol. 2018;1831:179–190.30051432
   PubMedGoogle Scholar
• Mahmoudi M, Sahraian MA, Shokrgozar MA, Laurent S. Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis. ACS Chem Neurosci. 2011;2(3):118–140. doi:10.1021/cn100100e22778862
   PubMed Web of Science ®Google Scholar
• Tsuchiya H, Mizogami M, Ueno T, Takakura K. Interaction of local anaesthetics with lipid membranes under inflammatory acidic conditions. Inflammopharmacology. 2007;15(4):164–170. doi:10.1007/s10787-007-1601-517701019
   PubMedGoogle Scholar
• Lin YL, Huang XF, Chang KF, Liao KW, Tsai NM. Encapsulated n-butylidenephthalide efficiently crosses the blood-brain barrier and suppresses growth of glioblastoma. Int J Nanomedicine. 2020;15:749–760. doi:10.2147/IJN.S23581532099363
   PubMed Web of Science ®Google Scholar
• Hoshino K, Kashiwamura S, Kuribayashi K, et al. The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function. J Exp Med. 1999;190(10):1541–1548. doi:10.1084/jem.190.10.154110562328
   PubMed Web of Science ®Google Scholar
• Oliphant CJ, Hwang YY, Walker JA, et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity. 2014;41(2):283–295. doi:10.1016/j.immuni.2014.06.01625088770
   PubMed Web of Science ®Google Scholar
• Halim TY, Steer CA, Mathä L, et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity. 2014;40(3):425–435. doi:10.1016/j.immuni.2014.01.01124613091
   PubMed Web of Science ®Google Scholar